BBOT

About BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT) Stock

BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT) closed the 2026-09-18 session at $4.77, down 2.45% versus the previous close (-0.12). The stock opened at $4.86 and traded between $4.74 and $4.86 during that session. Session trading volume was 436K shares. The volume-weighted average price (VWAP) is $4.77.

BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.

BridgeBio Oncology Therapeutics, Inc. Common Stock has a market capitalization of $392.1 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. BBOT is listed on the XNAS exchange. The company employs approximately 88 people. BridgeBio Oncology Therapeutics, Inc. Common Stock is headquartered in SOUTH SAN FRANCISCO, CA. The recorded listing date is 2025-08-12.

On this page you can find market BBOT stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.

Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.